JPRN-UMIN000008384Completed未知
Comparison of the effect of indacaterol versus salmeterol in patients with chronic obstructive pulmonary disease - Comparison of the effect of indacaterol versus salmeterol in patients with chronic obstructive pulmonary disease
St. Marianna University School of Medicine, Respiratory and infectious diseases0 sites20 target enrollmentStarted: July 10, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 30years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients experienced acute exacerbation within 8 weeks before the start of this study. 2. Patients with an unstable cardiac diseases. 3. Patients deemed as inappropriate for this study by investigators.
Investigators
Similar Trials
Completed
Phase 3
Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)NCT00821093Novartis Pharmaceuticals1,123
Recruiting
Phase 4
To compare Indacaterol and Tiotropium in patients of Chronic obstructive pulmonary disease.CTRI/2015/01/005430JNMCH AMU ALIGARH UP INDIA120
Completed
Not Applicable
Clinical effects of indacaterol in patients with COPDCOPDJPRN-UMIN000006724Atami Hospital International University of Health and Welfare50
Recruiting
Not Applicable
Comparison of indacaterol with tiotropium for stable COPDCOPDJPRN-UMIN000009951Shizuoka General Hospital30
Completed
Phase 1
Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent AsthmaAsthmaNCT00624702Novartis98